Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Acceptability of financial incentives for health-related behavior change: An updated systematic review.

Hoskins K, Ulrich CM, Shinnick J, Buttenheim AM.

Prev Med. 2019 Sep;126:105762. doi: 10.1016/j.ypmed.2019.105762. Epub 2019 Jul 2. Review.

PMID:
31271816
2.

The clinician crowdsourcing challenge: using participatory design to seed implementation strategies.

Stewart RE, Williams N, Byeon YV, Buttenheim A, Sridharan S, Zentgraf K, Jones DT, Hoskins K, Candon M, Beidas RS.

Implement Sci. 2019 Jun 14;14(1):63. doi: 10.1186/s13012-019-0914-2.

3.

BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.

Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, Jankowitz RC, Karlan BY, Kirk J, Kwong A, Lee A, Lesueur F, Lu KH, Nathanson KL, Neuhausen SL, Offit K, Palmero EI, Sharma P, Tischkowitz M, Toland AE, Tung N, van Rensburg EJ, Vega A, Weitzel JN, Collaborators GS, Hoskins KF, Maga T, Parsons MT, McGuffog L, Antoniou AC, Chenevix-Trench G, Huo D, Olopade OI, Rebbeck TR.

Hum Mutat. 2019 May 21. doi: 10.1002/humu.23804. [Epub ahead of print]

PMID:
31112363
4.

Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.

Cohen SA, Bradbury A, Henderson V, Hoskins K, Bednar E, Arun BK.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:e34-e44. doi: 10.1200/EDBK_238937. Epub 2019 May 17.

PMID:
31099680
5.

Potassium channel activity controls breast cancer metastasis by affecting β-catenin signaling.

Breuer EK, Fukushiro-Lopes D, Dalheim A, Burnette M, Zartman J, Kaja S, Wells C, Campo L, Curtis KJ, Romero-Moreno R, Littlepage LE, Niebur GL, Hoskins K, Nishimura MI, Gentile S.

Cell Death Dis. 2019 Feb 21;10(3):180. doi: 10.1038/s41419-019-1429-0.

6.

Tracking methods and retention for a longitudinal sample of alcohol- and drug-involved women on probation and parole.

Northcutt Bohmert M, Hoskins KM, Morash M.

J Community Psychol. 2019 Jun;47(5):1064-1077. doi: 10.1002/jcop.22170. Epub 2019 Feb 21.

PMID:
30791106
7.

A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.

Hoskins KF, Tejeda S, Vijayasiri G, Chukwudozie IB, Remo MH, Shah HA, Abraham IE, Balay LE, Maga TK, Searles ER, Korah VJ, Biggers A, Stolley MR, Warnecke RB.

Cancer. 2018 Sep 15;124(18):3733-3741. doi: 10.1002/cncr.31635. Epub 2018 Oct 15.

PMID:
30320429
8.

Views of Low-Income Women of Color at Increased Risk for Breast Cancer.

E Anderson E, Tejada S, B Warnecke R, Hoskins K.

Narrat Inq Bioeth. 2018;8(1):53-66. doi: 10.1353/nib.2018.0023.

9.

Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.

Abhyankar N, Hoskins KF, Abern MR, Calip GS.

BMC Cancer. 2017 Sep 25;17(1):659. doi: 10.1186/s12885-017-3640-7.

10.

Pain control with continuous infusion preperitoneal wound catheters versus continuous epidural analgesia in colon and rectal surgery: A randomized controlled trial.

Mouawad NJ, Leichtle SW, Kaoutzanis C, Welch K, Winter S, Lampman R, McCord M, Hoskins KA, Cleary RK.

Am J Surg. 2018 Apr;215(4):570-576. doi: 10.1016/j.amjsurg.2017.06.031. Epub 2017 Jul 1.

PMID:
28688514
11.

Efficacy of a Weight Loss Intervention for African American Breast Cancer Survivors.

Stolley M, Sheean P, Gerber B, Arroyo C, Schiffer L, Banerjee A, Visotcky A, Fantuzzi G, Strahan D, Matthews L, Dakers R, Carridine-Andrews C, Seligman K, Springfield S, Odoms-Young A, Hong S, Hoskins K, Kaklamani V, Sharp L.

J Clin Oncol. 2017 Aug 20;35(24):2820-2828. doi: 10.1200/JCO.2016.71.9856. Epub 2017 Jun 19.

12.

Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.

Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY.

J Oncol Pract. 2017 May;13(5):e451-e462. doi: 10.1200/JOP.2016.018317. Epub 2017 Mar 13.

PMID:
28287854
13.

Measures of economic advantage associated with HPV-positive head and neck cancers among non-Hispanic black and white males identified through the National Cancer Database.

Peterson CE, Khosla S, Jefferson GD, Davis FG, Fitzgibbon ML, Freels S, Johnson TP, Hoskins K, Joslin CE.

Cancer Epidemiol. 2017 Jun;48:1-7. doi: 10.1016/j.canep.2017.02.011. Epub 2017 Mar 7.

14.

Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities.

Rauscher GH, Silva A, Pauls H, Frasor J, Bonini MG, Hoskins K.

Breast Cancer Res Treat. 2017 Jun;163(2):321-330. doi: 10.1007/s10549-017-4166-z. Epub 2017 Mar 1.

15.

Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.

Dabbous FM, Dolecek TA, Berbaum ML, Friedewald SM, Summerfelt WT, Hoskins K, Rauscher GH.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):397-403. doi: 10.1158/1055-9965.EPI-16-0524. Epub 2017 Feb 9.

16.

Selenium levels in human breast carcinoma tissue are associated with a common polymorphism in the gene for SELENOP (Selenoprotein P).

Ekoue DN, Zaichick S, Valyi-Nagy K, Picklo M, Lacher C, Hoskins K, Warso MA, Bonini MG, Diamond AM.

J Trace Elem Med Biol. 2017 Jan;39:227-233. doi: 10.1016/j.jtemb.2016.11.003. Epub 2016 Nov 11.

17.

The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.

Beckmeyer-Borowko AB, Peterson CE, Brewer KC, Otoo MA, Davis FG, Hoskins KF, Joslin CE.

Cancer Causes Control. 2016 Oct;27(10):1261-71. doi: 10.1007/s10552-016-0806-6. Epub 2016 Sep 2.

18.

Racial differences in head and neck squamous cell carcinomas among non-Hispanic black and white males identified through the National Cancer Database (1998-2012).

Peterson CE, Khosla S, Chen LF, Joslin CE, Davis FG, Fitzgibbon ML, Freels S, Hoskins K.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1715-26. doi: 10.1007/s00432-016-2182-8. Epub 2016 Jun 1.

PMID:
27251759
19.

Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors.

Rauscher GH, Campbell RT, Wiley EL, Hoskins K, Stolley MR, Warnecke RB.

Am J Epidemiol. 2016 May 15;183(10):884-93. doi: 10.1093/aje/kwv226. Epub 2016 Apr 13.

20.

Racial and Ethnic Disparity in Symptomatic Breast Cancer Awareness despite a Recent Screen: The Role of Tumor Biology and Mammography Facility Characteristics.

Mortel M, Rauscher GH, Murphy AM, Hoskins K, Warnecke RB.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1599-606. doi: 10.1158/1055-9965.EPI-15-0305. Epub 2015 Jul 21.

21.

Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.

Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF.

J Oncol Pract. 2015 Jul;11(4):e460-7. doi: 10.1200/JOP.2014.003558. Epub 2015 Jun 2.

22.

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579).

Kaklamani VG, Jeruss JS, Hughes E, Siziopikou K, Timms KM, Gutin A, Abkevich V, Sangale Z, Solimeno C, Brown KL, Jones J, Hartman AR, Meservey C, Jovanovic B, Helenowski I, Khan SA, Bethke K, Hansen N, Uthe R, Giordano S, Rosen S, Hoskins K, Von Roenn J, Jain S, Parini V, Gradishar W.

Breast Cancer Res Treat. 2015 Jun;151(3):629-38. doi: 10.1007/s10549-015-3435-y. Epub 2015 May 26.

PMID:
26006067
23.

The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.

Brewer KC, Peterson CE, Davis FG, Hoskins K, Pauls H, Joslin CE.

Ann Epidemiol. 2015 Aug;25(8):556-63. doi: 10.1016/j.annepidem.2015.03.021. Epub 2015 Apr 18.

24.

Exploring Diet, Physical Activity, and Quality of Life in Females with Metastatic Breast Cancer: A Pilot Study to Support Future Intervention.

Sheean P, Kabir C, Rao R, Hoskins K, Stolley M.

J Acad Nutr Diet. 2015 Oct;115(10):1690-8. doi: 10.1016/j.jand.2015.03.017. Epub 2015 May 12.

25.

Associations between diabetes medication use and risk of second breast cancer events and mortality.

Calip GS, Yu O, Hoskins KF, Boudreau DM.

Cancer Causes Control. 2015 Aug;26(8):1065-77. doi: 10.1007/s10552-015-0599-z. Epub 2015 May 9.

26.

The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.

Joslin CE, Brewer KC, Davis FG, Hoskins K, Peterson CE, Pauls HA.

Gynecol Oncol. 2014 Nov;135(2):285-91. doi: 10.1016/j.ygyno.2014.08.029. Epub 2014 Aug 28.

27.

Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry.

Silva A, Rauscher GH, Ferrans CE, Hoskins K, Rao R.

J Registry Manag. 2014 Spring;41(1):24-30.

PMID:
24893185
28.

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.

Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG; Northwestern Cancer Genetics Group.

Cancer. 2014 May 15;120(10):1557-64. doi: 10.1002/cncr.28577. Epub 2014 Feb 12.

29.

Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines.

Silva A, Rauscher GH, Hoskins K, Rao R, Ferrans CE.

Breast Cancer Res Treat. 2013 Dec;142(3):667-72. doi: 10.1007/s10549-013-2759-8. Epub 2013 Nov 22.

30.

Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research.

Anderson EE, Hoskins K.

J Health Care Poor Underserved. 2012 Nov;23(4 Suppl):34-46. doi: 10.1353/hpu.2012.0178.

31.

Early stroke mortality, patient preferences, and the withdrawal of care bias.

Kelly AG, Hoskins KD, Holloway RG.

Neurology. 2012 Aug 28;79(9):941-4. doi: 10.1212/WNL.0b013e318266fc40.

32.

Body composition changes in females treated for breast cancer: a review of the evidence.

Sheean PM, Hoskins K, Stolley M.

Breast Cancer Res Treat. 2012 Oct;135(3):663-80. doi: 10.1007/s10549-012-2200-8. Epub 2012 Aug 19. Review.

33.

Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS.

Quinn C, Elman L, McCluskey L, Hoskins K, Karam C, Woo JH, Poptani H, Wang S, Chawla S, Kasner SE, Grossman M.

Neurology. 2012 Aug 7;79(6):583-8. doi: 10.1212/WNL.0b013e3182635720. Epub 2012 Jul 25.

34.

Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population.

Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M, Balcer LJ, Galetta SL, Liu GT.

J Neurol Sci. 2012 Mar 15;314(1-2):97-101. doi: 10.1016/j.jns.2011.10.016. Epub 2011 Dec 21.

35.

Amyotrophic lateral sclerosis: ethical challenges.

Johnston WS, Hoskins K, McCluskey L.

Neurology. 2011 Feb 15;76(7 Suppl 2):S1-5. doi: 10.1212/WNL.0b013e31820d57ee. No abstract available.

PMID:
21321345
36.

Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations.

Teller P, Hoskins KF, Zwaagstra A, Stanislaw C, Iyengar R, Green VL, Gabram SG.

Ann Surg Oncol. 2010 Jan;17(1):240-6. doi: 10.1245/s10434-009-0697-9. Epub 2009 Sep 18.

PMID:
19763692
37.

The timing of normalization of CA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer.

Rocconi RP, Matthews KS, Kemper MK, Hoskins KE, Huh WK, Straughn JM Jr.

Gynecol Oncol. 2009 Aug;114(2):242-5. doi: 10.1016/j.ygyno.2009.04.019. Epub 2009 May 17.

PMID:
19447480
38.

The effect of obesity on survival in patients with ovarian cancer.

Matthews KS, Straughn JM Jr, Kemper MK, Hoskins KE, Wang W, Rocconi RP.

Gynecol Oncol. 2009 Feb;112(2):389-93. doi: 10.1016/j.ygyno.2008.10.016. Epub 2008 Dec 5.

PMID:
19062080
39.

Chemical enhancement techniques of bloodstain patterns and DNA recovery after fire exposure.

Tontarski KL, Hoskins KA, Watkins TG, Brun-Conti L, Michaud AL.

J Forensic Sci. 2009 Jan;54(1):37-48. doi: 10.1111/j.1556-4029.2008.00904.x. Epub 2008 Nov 6.

PMID:
19018938
40.

Pregnancy and active Huntington disease: a rare combination.

Hoskins KE, Tita AT, Biggio JR, Ramsey PS.

J Perinatol. 2008 Feb;28(2):156-7. doi: 10.1038/sj.jp.7211874.

PMID:
18235509
41.

Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients.

Rocconi RP, Matthews KS, Kemper MK, Hoskins KE, Barnes MN.

Gynecol Oncol. 2008 Feb;108(2):336-41. Epub 2007 Nov 19.

PMID:
18006047
42.
43.

Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers.

Elkahloun AG, Bittner M, Hoskins K, Gemmill R, Meltzer PS.

Genes Chromosomes Cancer. 1996 Dec;17(4):205-14.

PMID:
8946202
44.

Recent advances in breast cancer biology.

Hoskins K, Weber BL.

Curr Opin Oncol. 1995 Nov;7(6):495-500. Review.

PMID:
8547395
45.

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL.

JAMA. 1995 Feb 15;273(7):577-85.

PMID:
7837392
46.

A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, et al.

JAMA. 1995 Feb 15;273(7):535-41.

PMID:
7837387
47.

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, et al.

Nat Genet. 1994 Dec;8(4):387-91.

PMID:
7894491
48.

The biology of breast cancer.

Hoskins K, Weber BL.

Curr Opin Oncol. 1994 Nov;6(6):554-9. Review.

PMID:
7827164
49.

Supplemental Content

Loading ...
Support Center